For the past month, Johnson & Johnson's (NYSE:JNJ) share price has followed the long-term trend in health care spending, moving steadily up and to the right. With shares now sitting near their 52-week and all-time highs, our health-care bureau chief Brenton Flynn was anxiously awaiting today's earnings report to take a pulse on the $200 billion health care giant.
Motley Fool Returns
Discounted offers are only available to new members. Stock Advisor will renew at the then current list price. Stock Advisor list price is $199 per year.
Stock Advisor launched in February of 2002. Returns as of 01/24/2022.
Average returns of all recommendations since inception. Cost basis and return based on previous market day close.